Gene Therapy Rebuilds 'Bubble Boy' Immune System
Gene Therapy Rebuilds 'Bubble Boy' Immune System
Gene Therapy Rebuilds 'Bubble Boy' Immune System
Key points
اہم نکات
मुख्य बातें
- Matthew Rozek, a 29-year-old Melbourne man born without a working immune system, has become one of the first people in the world to receive an experimental gene therapy that is rebuilding his immunity.
- Known as 'bubble boy disease', his severe combined immunodeficiency meant a life avoiding everyday germs, and a childhood bone marrow transplant had slowly failed.
- After treatment at the US National Institutes of Health, where his own stem cells were genetically repaired and returned, his immune system is improving, he has gained 10 kilograms and come off some medicines.
- Matthew Rozek, a 29-year-old Melbourne man born without a working immune system, has become one of the first people in the world to receive an experimental gene therapy that is rebuilding his immunity.
- Known as 'bubble boy disease', his severe combined immunodeficiency meant a life avoiding everyday germs, and a childhood bone marrow transplant had slowly failed.
- After treatment at the US National Institutes of Health, where his own stem cells were genetically repaired and returned, his immune system is improving, he has gained 10 kilograms and come off some medicines.
- Matthew Rozek, a 29-year-old Melbourne man born without a working immune system, has become one of the first people in the world to receive an experimental gene therapy that is rebuilding his immunity.
- Known as 'bubble boy disease', his severe combined immunodeficiency meant a life avoiding everyday germs, and a childhood bone marrow transplant had slowly failed.
- After treatment at the US National Institutes of Health, where his own stem cells were genetically repaired and returned, his immune system is improving, he has gained 10 kilograms and come off some medicines.
Matthew Rozek, a 29-year-old Melbourne man born without a working immune system, has become one of the first people in the world to receive an experimental gene therapy that is rebuilding his immunity. Known as 'bubble boy disease', his severe combined immunodeficiency meant a life avoiding everyday germs, and a childhood bone marrow transplant had slowly failed. After treatment at the US National Institutes of Health, where his own stem cells were genetically repaired and returned, his immune system is improving, he has gained 10 kilograms and come off some medicines. Doctors say the treatment offers hope of a normal life, though it cannot undo decades of damage.
Matthew Rozek, a 29-year-old Melbourne man born without a working immune system, has become one of the first people in the world to receive an experimental gene therapy that is rebuilding his immunity. Known as 'bubble boy disease', his severe combined immunodeficiency meant a life avoiding everyday germs, and a childhood bone marrow transplant had slowly failed. After treatment at the US National Institutes of Health, where his own stem cells were genetically repaired and returned, his immune system is improving, he has gained 10 kilograms and come off some medicines. Doctors say the treatment offers hope of a normal life, though it cannot undo decades of damage.
Matthew Rozek, a 29-year-old Melbourne man born without a working immune system, has become one of the first people in the world to receive an experimental gene therapy that is rebuilding his immunity. Known as 'bubble boy disease', his severe combined immunodeficiency meant a life avoiding everyday germs, and a childhood bone marrow transplant had slowly failed. After treatment at the US National Institutes of Health, where his own stem cells were genetically repaired and returned, his immune system is improving, he has gained 10 kilograms and come off some medicines. Doctors say the treatment offers hope of a normal life, though it cannot undo decades of damage.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।